Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Switzerland Companies

Sucampo forms holding company to improve efficiency

This article was originally published in Scrip

Executive Summary

Sucampo Pharmaceuticals is to set itself up with a holding company to provide a more efficient corporate structure. After the changes, Sucampo Pharmaceuticals Inc will be the public company, with three wholly owned subsidiaries: Sucampo Pharma Ltd based in Tokyo and Osaka; Sucampo Pharma Americas Inc, based in Bethesda; andSucampo Pharma Europe, based in Oxford, UK, and Basel, Switzerland. Dr Sachiko Kuno, a co-founder of the company and a former CEO, will rejoin the board on completion of the changes. The company will also undertake a stock buyback of up to $10 million, and has promoted its acting chief financial officer, Jan Smilek, to CFO.

Table

View full table

Topics

Related Companies

Tags:
Switzerland Companies
Latest Headlines

Japan Results Roundup: Weak Yen Provides A Boost But Some Sales Challenges Emerge

Deal Watch: Bristol Adds To Vaccines ‘Repertoire,’ Takes ‘Scenic’ View Of Cellular Pathways

Navigating A Transition Year: Five Takeaways From Pfizer’s Q1 Call

Astellas Stakes Claim In CAR-Ts For Solid Tumors With Poseida Deal

See All
UsernamePublicRestriction

Register

SC007675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By